Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study
|更新时间:2026-01-27
|
Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study
China OncologyVol. 31, Issue 4, Pages: 323-329(2021)
曾 峰, 李 丹, 邵鑫鑫, et al. Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study[J]. China Oncology, 2021, 31(4): 323-329.
曾 峰, 李 丹, 邵鑫鑫, et al. Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study[J]. China Oncology, 2021, 31(4): 323-329. DOI: 10.19401/j.cnki.1007-3639.2021.04.012.
Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study
Background and purpose: Guidelines recommend that the axillary lymph node dissection can be omitted for T 1-2 breast cancer patients with 1-2 positive sentinel lymph nodes who undergo breast-conserving mastectomy and whole breast radiation. This study aimed to explore the independent prognostic factors for elderly breast cancer patients with 1-2 positive lymph nodes who underwent mastectomy and construct a nomogram to predict their survival following different axillary surgeries. Methods: T 1-2 invasive breast cancer patients with 1-2 positive nodes and mastectomy from 2010 to 2015 were extracted from the Surveillance
Epidemiology
and End Results (SEER) program and divided into the training cohort (n=3 647) and the validation cohort (n=1 216). Univariate and multivariate Cox analyses were used to identify independent risk factors for overall survival (OS). The nomogram was constructed to predict 3- and 5-year OS
which was validated by the concordance index (C-index) and calibration curves. Results: A total of 4 863 patients were included with a 42 months median follow-up time. The nomogram was constructed by incorporating nine independent prognostic factors (age
race
marital status
grade
subtype
T stage
axillary surgery
radiation and chemotherapy) identified by multivariate Cox analysis (P0.05). The C-index was 0.710 (95% CI: 0.689-0.731) in the training cohort and 0.728 (95% CI: 0.691-0.765) in the validation cohort. All calibration curves showed good predictive capabilities. Conclusion: The well-validated nomogram was constructed and could be useful for individual treatment in the clinic.
Axillary management after neoadjuvant therapy for breast cancer and optimization of sentinel lymph node diagnosis and treatment
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China
Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14
Related Author
Jiaqian ZHONG
Jiaping LI
Xiaoyan XIE
Yanling ZHENG
The Society of Breast Cancer China Anti-Cancer Association
Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
LU Ye
ZHANG Wenxiang
Related Institution
Department of Ultrasound, First Affiliated Hospital of Sun Yat-sen University
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases